Michael Weller

University Hospital of Zurich (CH)

Research Areas

Discover Papers by Michael Weller

Access 250+ million papers and cite this researcher's work with AI assistance

Try AnswerThis Free →

H-index

176

Publications

2818

Citations

165197

i10-index

1098

Publications & Citations Over Time

Top Cited Publications

Want to find and read papers by this researcher? AnswerThis gives you instant access.

Title	Year	Citations
Radiotherapy plus Concomitant and Adjuvant Temozol...	2005	21335
Effects of radiotherapy with concomitant and adjuv...	2009	7725
<i>MGMT</i> Gene Silencing and Benefit from Temozo...	2005	7176
Effect of Tumor-Treating Fields Plus Maintenance T...	2017	2517
An endogenous tumour-promoting ligand of the human...	2011	1829
EANO guidelines on the diagnosis and treatment of ...	2020	1823
Effect of Nivolumab vs Bevacizumab in Patients Wit...	2020	1404
Current state of immunotherapy for glioblastoma	2018	1382
Type and frequency of IDH1 and IDH2 mutations are ...	2009	1149
Glioma	2015	1136

Publications

1.
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Year: 2005Citations: 21335DOI: 10.1056/nejmoa043330
2.
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Year: 2009Citations: 7725DOI: 10.1016/s1470-2045(09)70025-7
3.
<i>MGMT</i> Gene Silencing and Benefit from Temozolomide in Glioblastoma
Year: 2005Citations: 7176DOI: 10.1056/nejmoa043331
4.
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
Year: 2017Citations: 2517DOI: 10.1001/jama.2017.18718
5.
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
Year: 2011Citations: 1829DOI: 10.1038/nature10491
6.
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Year: 2020Citations: 1823DOI: 10.1038/s41571-020-00447-z
7.
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma
Year: 2020Citations: 1404DOI: 10.1001/jamaoncol.2020.1024
8.
Current state of immunotherapy for glioblastoma
Year: 2018Citations: 1382DOI: 10.1038/s41571-018-0003-5
9.
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Year: 2009Citations: 1149DOI: 10.1007/s00401-009-0561-9
10.
Glioma
Year: 2015Citations: 1136DOI: 10.1038/nrdp.2015.17

About Michael Weller

Michael Weller is a researcher with 2818 publications and 165197 citations. They are affiliated with University Hospital of Zurich. Their research focuses on . With an h-index of 176, they are among the top researchers in their field.

Citation Distribution

Distribution of citations across publications

Research Smarter

AnswerThis uses AI to help you search, understand, and cite research from Michael Weller and 250M+ other papers.

AI-powered research assistance
Automatic citations and references
Advanced academic writing tools

Research Area Breakdown

Publication Types

Publication type data not available

Impact Metrics Over Time

Citations per publication by year